NCT03160677View on ClinicalTrials.gov

Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy

NACompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

December 31, 2019

Study Completion Date

January 31, 2020

Conditions
Acute StrokeBlood PressureCerebral Hemorrhage
Interventions
OTHER

Systolic blood pressure target < 130 mm Hg

Adaptation of antihypertensive treatments to reach the Systolic blood pressure target \< 130 mm Hg

OTHER

Systolic blood pressure target < 185 mm Hg

Adaptation of antihypertensive treatments to reach the Systolic blood pressure target \< 185 mm Hg

Trial Locations (7)

75010

Hopital Lariboisière, Paris

75019

Fondation Ophtalmologique A de Rothschild, Paris

Unknown

CHU de Bordeaux, Bordeaux

Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon

Centre Hospitalier Régional Universitaire, Nancy

Hopital Foch, Suresnes

31 100

Hopital de purpan, Toulouse

All Listed Sponsors
lead

Fondation Ophtalmologique Adolphe de Rothschild

NETWORK

NCT03160677 - Blood Pressure Target in Acute Stroke to Reduce hemorrhaGe After Endovascular Therapy | Biotech Hunter | Biotech Hunter